UniProt ID | BACH_HUMAN | |
---|---|---|
UniProt AC | O00154 | |
Protein Name | Cytosolic acyl coenzyme A thioester hydrolase | |
Gene Name | ACOT7 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 380 | |
Subcellular Localization |
Isoform 4: Cytoplasm. Isoform 6: Cytoplasm. Isoform 1: Mitochondrion. Isoform 5: Mitochondrion. |
|
Protein Description | Acyl-CoA thioesterases are a group of enzymes that catalyze the hydrolysis of acyl-CoAs to the free fatty acid and coenzyme A (CoASH), providing the potential to regulate intracellular levels of acyl-CoAs, free fatty acids and CoASH. May play an important physiological function in brain. May play a regulatory role by modulating the cellular levels of fatty acyl-CoA ligands for certain transcription factors as well as the substrates for fatty acid metabolizing enzymes, contributing to lipid homeostasis. Has broad specificity, active towards fatty acyl-CoAs with chain-lengths of C8-C18. Has a maximal activity toward palmitoyl-CoA.. | |
Protein Sequence | MKLLARALRLCEFGRQASSRRLVAGQGCVGPRRGCCAPVQVVGPRADLPPCGACITGRIMRPDDANVAGNVHGGTILKMIEEAGAIISTRHCNSQNGERCVAALARVERTDFLSPMCIGEVAHVSAEITYTSKHSVEVQVNVMSENILTGAKKLTNKATLWYVPLSLKNVDKVLEVPPVVYSRQEQEEEGRKRYEAQKLERMETKWRNGDIVQPVLNPEPNTVSYSQSSLIHLVGPSDCTLHGFVHGGVTMKLMDEVAGIVAARHCKTNIVTASVDAINFHDKIRKGCVITISGRMTFTSNKSMEIEVLVDADPVVDSSQKRYRAASAFFTYVSLSQEGRSLPVPQLVPETEDEKKRFEEGKGRYLQMKAKRQGHAEPQP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 (in isoform 2) | Phosphorylation | - | 52.81 | 25159151 | |
2 (in isoform 4) | Phosphorylation | - | 52.81 | 25159151 | |
2 | Ubiquitination | ------MKLLARALR ------CHHHHHHHH | 52.81 | - | |
2 (in isoform 3) | Phosphorylation | - | 52.81 | 25159151 | |
8 (in isoform 2) | Phosphorylation | - | 3.42 | 26270265 | |
8 (in isoform 3) | Phosphorylation | - | 3.42 | 26270265 | |
8 (in isoform 4) | Phosphorylation | - | 3.42 | 26270265 | |
10 (in isoform 2) | Phosphorylation | - | 3.23 | 25693802 | |
10 (in isoform 3) | Phosphorylation | - | 3.23 | 25693802 | |
10 (in isoform 4) | Phosphorylation | - | 3.23 | 25693802 | |
27 | Acetylation | RRLVAGQGCVGPRRG CCEECCCCCCCCCCC | 13.73 | 19608861 | |
34 (in isoform 7) | Phosphorylation | - | 16.49 | 22617229 | |
40 (in isoform 7) | Phosphorylation | - | 24.10 | 26270265 | |
42 (in isoform 7) | Phosphorylation | - | 4.96 | 25693802 | |
48 | Acetylation | VVGPRADLPPCGACI EECCCCCCCCCCCEE | 5.07 | 19608861 | |
68 | Acetylation | RPDDANVAGNVHGGT CCCCCCCCCCCCCHH | 12.03 | 19608861 | |
78 | Acetylation | VHGGTILKMIEEAGA CCCHHHHHHHHHHCC | 33.70 | 19608861 | |
101 | Ubiquitination | SQNGERCVAALARVE CCCHHHHHHHHHCCC | 4.35 | 22817900 | |
102 | Ubiquitination | QNGERCVAALARVER CCHHHHHHHHHCCCC | 10.61 | 22817900 | |
106 | Ubiquitination | RCVAALARVERTDFL HHHHHHHCCCCCCCC | 31.51 | 21890473 | |
106 (in isoform 6) | Ubiquitination | - | 31.51 | 21890473 | |
115 (in isoform 2) | Ubiquitination | - | 24.66 | 21890473 | |
115 (in isoform 3) | Ubiquitination | - | 24.66 | 21890473 | |
117 | Ubiquitination | TDFLSPMCIGEVAHV CCCCCCHHHHEEEEE | 4.03 | 23000965 | |
117 | Acetylation | TDFLSPMCIGEVAHV CCCCCCHHHHEEEEE | 4.03 | 19608861 | |
117 (in isoform 6) | Ubiquitination | - | 4.03 | 21890473 | |
121 | Ubiquitination | SPMCIGEVAHVSAEI CCHHHHEEEEEEEEE | 3.63 | 23000965 | |
122 | Ubiquitination | PMCIGEVAHVSAEIT CHHHHEEEEEEEEEE | 7.96 | 22817900 | |
123 | Ubiquitination | MCIGEVAHVSAEITY HHHHEEEEEEEEEEE | 21.17 | 22817900 | |
126 (in isoform 2) | Ubiquitination | - | 15.89 | 21890473 | |
126 (in isoform 3) | Ubiquitination | - | 15.89 | 21890473 | |
127 | Ubiquitination | EVAHVSAEITYTSKH EEEEEEEEEEEECCC | 28.49 | 21890473 | |
127 (in isoform 5) | Ubiquitination | - | 28.49 | 21890473 | |
138 | Ubiquitination | TSKHSVEVQVNVMSE ECCCEEEEEEEECCC | 7.84 | 23000965 | |
138 | Acetylation | TSKHSVEVQVNVMSE ECCCEEEEEEEECCC | 7.84 | 19608861 | |
138 (in isoform 5) | Ubiquitination | - | 7.84 | 21890473 | |
142 | Ubiquitination | SVEVQVNVMSENILT EEEEEEEECCCCCCC | 4.73 | 23000965 | |
143 | Ubiquitination | VEVQVNVMSENILTG EEEEEEECCCCCCCC | 3.33 | 22817900 | |
147 | Ubiquitination | VNVMSENILTGAKKL EEECCCCCCCCCHHH | 2.98 | 22817900 | |
147 | Ubiquitination | VNVMSENILTGAKKL EEECCCCCCCCCHHH | 2.98 | 21890473 | |
147 (in isoform 4) | Ubiquitination | - | 2.98 | 21890473 | |
152 | Ubiquitination | ENILTGAKKLTNKAT CCCCCCCHHHCCCCE | 50.05 | 22817900 | |
153 | Ubiquitination | NILTGAKKLTNKATL CCCCCCHHHCCCCEE | 61.07 | 22817900 | |
153 | Acetylation | NILTGAKKLTNKATL CCCCCCHHHCCCCEE | 61.07 | 25953088 | |
154 | Ubiquitination | ILTGAKKLTNKATLW CCCCCHHHCCCCEEE | 6.68 | 32015554 | |
157 | Acetylation | GAKKLTNKATLWYVP CCHHHCCCCEEEEEE | 37.20 | 23954790 | |
157 | Ubiquitination | GAKKLTNKATLWYVP CCHHHCCCCEEEEEE | 37.20 | 21890473 | |
157 (in isoform 1) | Ubiquitination | - | 37.20 | 21890473 | |
158 | Ubiquitination | AKKLTNKATLWYVPL CHHHCCCCEEEEEEC | 15.25 | 23000965 | |
158 | Ubiquitination | AKKLTNKATLWYVPL CHHHCCCCEEEEEEC | 15.25 | 21890473 | |
158 | Acetylation | AKKLTNKATLWYVPL CHHHCCCCEEEEEEC | 15.25 | 19608861 | |
158 (in isoform 4) | Ubiquitination | - | 15.25 | 21890473 | |
159 | Phosphorylation | KKLTNKATLWYVPLS HHHCCCCEEEEEECC | 21.31 | 68724543 | |
162 | Phosphorylation | TNKATLWYVPLSLKN CCCCEEEEEECCCCC | 8.70 | 68710517 | |
162 | Ubiquitination | TNKATLWYVPLSLKN CCCCEEEEEECCCCC | 8.70 | 23000965 | |
166 | Phosphorylation | TLWYVPLSLKNVDKV EEEEEECCCCCCCCE | 31.09 | 20068231 | |
168 | Acetylation | WYVPLSLKNVDKVLE EEEECCCCCCCCEEE | 52.10 | 19608861 | |
168 | Ubiquitination | WYVPLSLKNVDKVLE EEEECCCCCCCCEEE | 52.10 | 23000965 | |
168 (in isoform 1) | Ubiquitination | - | 52.10 | 21890473 | |
172 | Acetylation | LSLKNVDKVLEVPPV CCCCCCCCEEECCCE | 44.42 | 23954790 | |
172 | Ubiquitination | LSLKNVDKVLEVPPV CCCCCCCCEEECCCE | 44.42 | 23000965 | |
172 | Malonylation | LSLKNVDKVLEVPPV CCCCCCCCEEECCCE | 44.42 | 26320211 | |
175 | Ubiquitination | KNVDKVLEVPPVVYS CCCCCEEECCCEEEC | 56.84 | 32015554 | |
181 | Phosphorylation | LEVPPVVYSRQEQEE EECCCEEECHHHHHH | 9.81 | 142163 | |
182 | Phosphorylation | EVPPVVYSRQEQEEE ECCCEEECHHHHHHH | 18.84 | 25394399 | |
188 | Ubiquitination | YSRQEQEEEGRKRYE ECHHHHHHHHHHHHH | 66.50 | 32015554 | |
188 | Acetylation | YSRQEQEEEGRKRYE ECHHHHHHHHHHHHH | 66.50 | 19608861 | |
194 | Phosphorylation | EEEGRKRYEAQKLER HHHHHHHHHHHHHHH | 20.74 | 28152594 | |
195 | Ubiquitination | EEGRKRYEAQKLERM HHHHHHHHHHHHHHH | 48.97 | 32015554 | |
198 | Acetylation | RKRYEAQKLERMETK HHHHHHHHHHHHHHH | 60.40 | 19608861 | |
198 | Ubiquitination | RKRYEAQKLERMETK HHHHHHHHHHHHHHH | 60.40 | 19608861 | |
205 | Ubiquitination | KLERMETKWRNGDIV HHHHHHHHCCCCCCC | 30.74 | 32015554 | |
232 | Ubiquitination | YSQSSLIHLVGPSDC EECCCCEEEECCCCC | 21.54 | 21890473 | |
232 | Acetylation | YSQSSLIHLVGPSDC EECCCCEEEECCCCC | 21.54 | 19608861 | |
232 (in isoform 6) | Ubiquitination | - | 21.54 | 21890473 | |
235 | Ubiquitination | SSLIHLVGPSDCTLH CCCEEEECCCCCEEE | 23.50 | 22817900 | |
253 | Ubiquitination | HGGVTMKLMDEVAGI CCCCHHHHHHHHHHH | 3.48 | 21890473 | |
253 | Acetylation | HGGVTMKLMDEVAGI CCCCHHHHHHHHHHH | 3.48 | 19608861 | |
253 (in isoform 5) | Ubiquitination | - | 3.48 | 21890473 | |
254 | Sulfoxidation | GGVTMKLMDEVAGIV CCCHHHHHHHHHHHH | 3.26 | 21406390 | |
256 | Ubiquitination | VTMKLMDEVAGIVAA CHHHHHHHHHHHHHH | 21.94 | 22817900 | |
267 | Ubiquitination | IVAARHCKTNIVTAS HHHHHCCCCCEEEEE | 38.18 | - | |
268 | Phosphorylation | VAARHCKTNIVTASV HHHHCCCCCEEEEEC | 35.26 | 20068231 | |
270 | Ubiquitination | ARHCKTNIVTASVDA HHCCCCCEEEEECCE | 3.35 | 22053931 | |
272 | Phosphorylation | HCKTNIVTASVDAIN CCCCCEEEEECCEEE | 14.93 | 20068231 | |
273 | Ubiquitination | CKTNIVTASVDAINF CCCCEEEEECCEEEC | 9.17 | 21890473 | |
273 | Ubiquitination | CKTNIVTASVDAINF CCCCEEEEECCEEEC | 9.17 | 21890473 | |
273 | Acetylation | CKTNIVTASVDAINF CCCCEEEEECCEEEC | 9.17 | 19608861 | |
273 (in isoform 4) | Ubiquitination | - | 9.17 | 21890473 | |
274 | Phosphorylation | KTNIVTASVDAINFH CCCEEEEECCEEECC | 15.91 | 20068231 | |
276 | Ubiquitination | NIVTASVDAINFHDK CEEEEECCEEECCHH | 38.95 | 22817900 | |
283 | Acetylation | DAINFHDKIRKGCVI CEEECCHHHCCCCEE | 35.52 | 19608861 | |
283 | Ubiquitination | DAINFHDKIRKGCVI CEEECCHHHCCCCEE | 35.52 | 22817900 | |
283 | 2-Hydroxyisobutyrylation | DAINFHDKIRKGCVI CEEECCHHHCCCCEE | 35.52 | - | |
283 (in isoform 1) | Ubiquitination | - | 35.52 | 21890473 | |
286 | Ubiquitination | NFHDKIRKGCVITIS ECCHHHCCCCEEEEC | 61.20 | 22817900 | |
286 | Malonylation | NFHDKIRKGCVITIS ECCHHHCCCCEEEEC | 61.20 | 26320211 | |
286 | Acetylation | NFHDKIRKGCVITIS ECCHHHCCCCEEEEC | 61.20 | 26051181 | |
291 | Ubiquitination | IRKGCVITISGRMTF HCCCCEEEECCEEEE | 6.68 | 22053931 | |
300 | Phosphorylation | SGRMTFTSNKSMEIE CCEEEECCCCCEEEE | 37.76 | 30624053 | |
303 | Phosphorylation | MTFTSNKSMEIEVLV EEECCCCCEEEEEEE | 26.37 | 30624053 | |
304 | Sulfoxidation | TFTSNKSMEIEVLVD EECCCCCEEEEEEEE | 6.85 | 30846556 | |
304 | Ubiquitination | TFTSNKSMEIEVLVD EECCCCCEEEEEEEE | 6.85 | 24816145 | |
305 | Ubiquitination | FTSNKSMEIEVLVDA ECCCCCEEEEEEEEC | 42.99 | 24816145 | |
311 | Ubiquitination | MEIEVLVDADPVVDS EEEEEEEECCCCCCC | 40.88 | 22053931 | |
318 | Ubiquitination | DADPVVDSSQKRYRA ECCCCCCCHHHHHHH | 24.06 | 33845483 | |
319 | Phosphorylation | ADPVVDSSQKRYRAA CCCCCCCHHHHHHHH | 34.95 | 24719451 | |
321 | Acetylation | PVVDSSQKRYRAASA CCCCCHHHHHHHHHH | 54.03 | 7350191 | |
321 | Ubiquitination | PVVDSSQKRYRAASA CCCCCHHHHHHHHHH | 54.03 | 22053931 | |
321 (in isoform 1) | Ubiquitination | - | 54.03 | 21890473 | |
325 | Ubiquitination | SSQKRYRAASAFFTY CHHHHHHHHHHHHEE | 9.24 | 24816145 | |
326 | Ubiquitination | SQKRYRAASAFFTYV HHHHHHHHHHHHEEE | 7.75 | 24816145 | |
327 | Phosphorylation | QKRYRAASAFFTYVS HHHHHHHHHHHEEEE | 25.32 | 102778137 | |
336 | Phosphorylation | FFTYVSLSQEGRSLP HHEEEEECCCCCCCC | 20.76 | 30624053 | |
339 | Ubiquitination | YVSLSQEGRSLPVPQ EEEECCCCCCCCCCC | 19.48 | 33845483 | |
345 | Ubiquitination | EGRSLPVPQLVPETE CCCCCCCCCCCCCCH | 21.61 | 24816145 | |
346 | Ubiquitination | GRSLPVPQLVPETED CCCCCCCCCCCCCHH | 56.16 | 24816145 | |
351 | Phosphorylation | VPQLVPETEDEKKRF CCCCCCCCHHHHHHH | 42.54 | 110734971 | |
355 | Ubiquitination | VPETEDEKKRFEEGK CCCCHHHHHHHHCCC | 62.66 | 24816145 | |
355 | 2-Hydroxyisobutyrylation | VPETEDEKKRFEEGK CCCCHHHHHHHHCCC | 62.66 | - | |
355 | Acetylation | VPETEDEKKRFEEGK CCCCHHHHHHHHCCC | 62.66 | 25953088 | |
356 | Ubiquitination | PETEDEKKRFEEGKG CCCHHHHHHHHCCCC | 61.34 | 24816145 | |
359 | Ubiquitination | EDEKKRFEEGKGRYL HHHHHHHHCCCCHHH | 70.63 | 33845483 | |
365 | Phosphorylation | FEEGKGRYLQMKAKR HHCCCCHHHHHHHHH | 15.23 | 28102081 | |
369 | Ubiquitination | KGRYLQMKAKRQGHA CCHHHHHHHHHCCCC | 37.48 | 33845483 | |
369 | Acetylation | KGRYLQMKAKRQGHA CCHHHHHHHHHCCCC | 37.48 | 25953088 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of BACH_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BACH_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BACH_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
AL9A1_HUMAN | ALDH9A1 | physical | 22863883 | |
G3P_HUMAN | GAPDH | physical | 22863883 | |
PDIA3_HUMAN | PDIA3 | physical | 22863883 | |
RCC2_HUMAN | RCC2 | physical | 22863883 | |
DHSO_HUMAN | SORD | physical | 22863883 | |
UBQL1_HUMAN | UBQLN1 | physical | 25416956 | |
THAP1_HUMAN | THAP1 | physical | 25416956 | |
PCBP1_HUMAN | PCBP1 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-78; LYS-168; LYS-198 ANDLYS-283, AND MASS SPECTROMETRY. |